Nektar Therapeutics (NKTR) declined -6.47% or -5.09 to $73.64. It is around 1.81 million shares traded, which is 69.31% compare to the average total volume 2.62 million. The market cap of NKTR is $11.60 billion. The year to date change is 36.57%. The 52 week price range is from $12.5 to $99.02. Price of NKTR have changed -5.84% during last week. It have changed 36.31% over last month, N/A N/A N/A
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NKTR is 63.54. It is -13.72% below current price. The 200-day Moving Averages for NKTR is 32.33. It is -56.10% below current price. The 52-week High is 99.02. It is 34.46% from the current price. The 52-week Low is 12.5. It is -83.03% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NKTR is 4.82 on 2018-01-12. Short % to float is 6.67%. There are some statistics of NKTR. It is has market cap $11.60 billion. The share outstanding is 157.47 million. The average volume is 2.62 million. The revenue is 249.70M. It has 1.37B cash and 992.36M in debt. The gross profit is 222.30M. The percent of top 15 Institution holding is 85.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NKTR is -1288.43%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NKTR is -20.86%.